Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01958073
What this trial is testing

Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women

Who this might be right for
Recurrent Urinary Tract Infection
University of California, San Diego 35
Testing effectiveness (Phase 2)Study completedNCT00050141
What this trial is testing

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

Who this might be right for
Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 121
Not applicableStudy completedNCT00611104
What this trial is testing

Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women

Who this might be right for
Breast Cancer
Mayo Clinic 20
Not applicableLooking for participantsNCT04167033
What this trial is testing

Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP)

Who this might be right for
Premature Ovarian Insufficiency
Assistance Publique - Hôpitaux de Paris 120
Early research (Phase 1)Study completedNCT01104259
What this trial is testing

Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerHereditary Breast/Ovarian Cancer - BRCA1+6 more
University of Washington 50
Early research (Phase 1)Ended earlyNCT02384746
What this trial is testing

Phase I Study of the Combination of MLN9708 and Fulvestrant

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 9
Early research (Phase 1)WithdrawnNCT02627430
What this trial is testing

Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer

Who this might be right for
Adult Solid NeoplasmEstrogen Receptor NegativeFallopian Tube Serous Neoplasm+10 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT01370798
What this trial is testing

Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications

Who this might be right for
Hypospadias
Hospices Civils de Lyon 244
Testing effectiveness (Phase 2)WithdrawnNCT01013506
What this trial is testing

Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Study completedNCT04546347
What this trial is testing

Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833

Who this might be right for
Healthy Volunteers
AstraZeneca 32
Not applicableWithdrawnNCT01123135
What this trial is testing

The Effect of Vaginal Estrogen Cream on Subjective and Objective Symptoms of Urodynamic Stress Incontinence

Who this might be right for
Stress Urinary Incontinence
University of California, Irvine
Testing effectiveness (Phase 2)Active Not RecruitingNCT04576455
What this trial is testing

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

Who this might be right for
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 303
Post-approval studies (Phase 4)Study completedNCT05551949
What this trial is testing

Preventing Recurrent UTI With Vaginal Estrogen

Who this might be right for
Recurrent Urinary Tract InfectionUrinary Tract InfectionsCystitis Recurrent
Johns Hopkins University 27
Not applicableEnded earlyNCT01346579
What this trial is testing

Biomarkers in Tissue Samples From Older Women With Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 505
Early research (Phase 1)Study completedNCT01339442
What this trial is testing

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IV Breast Cancer
Washington University School of Medicine 31
Testing effectiveness (Phase 2)Study completedNCT03213041
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Northwestern University 12
Not applicableNot Yet RecruitingNCT07791394
What this trial is testing

Does Estrogen Blunt the Effects of Exercise Training on Glycemic Control

Who this might be right for
To Determine Whether Estrogen Influences the Effects of Training on Glycemic Control and Insulin Sensitivity
University of Waterloo 24
Large-scale testing (Phase 3)Study completedNCT01070979
What this trial is testing

Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.

Who this might be right for
Hormone Replacement Therapy
Warner Chilcott 249
Post-approval studies (Phase 4)Study completedNCT06633705
What this trial is testing

Changes in Neighbouring Microbiota in Genitourinary Syndrome

Who this might be right for
Genitourinary Syndrome of Menopause
Koc University Hospital 31
Testing effectiveness (Phase 2)UnknownNCT03192293
What this trial is testing

Metformin and Simvastatin in Addition to Fulvestrant

Who this might be right for
Breast Cancer
National University Hospital, Singapore 28
Next Page